"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
A study looking at 2 new treatments for prostate cancer that does not respond to hormone therapy
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
This study wanted to see if 2 drugs for diabetes and high cholesterol helped to reduce PSA levels in prostate cancer when hormone therapy was no longer working.
More about this trial
When this happens you may not have symptoms. But your
Researchers wanted to see if 2 drugs designed to treat other conditions, would help to stabilise or lower the PSA.
These drugs do not have such severe side effects as steroids or chemotherapy. Pioglitazone treats diabetes, but is still safe if you are not diabetic. Fenofibrate treats high cholesterol.
The aims of this study were to:
- see how these drugs affect PSA levels in men with symptom free hormone resistant prostate cancer
- find out more about the side effects
- see how these drugs affected
quality of life
Summary of results
The study team have told us that this trial closed early because they found it difficult to get enough men to take part. This means that they have not been able to do a full analysis of the results.
How to join a clinical trial
Dr Jonathan Shamash
Barts Health NHS Trust
Experimental Cancer Medicine Centre (ECMC)
Orchid Cancer Appeal